Response and therapeutic failure to meglumine antimoniate, the first-line drug for cutaneous leishmaniasis infections in Colombian soldiers. [PDF]
Pavia PX +6 more
europepmc +1 more source
"High specificity of PCR in diagnosing mucocutaneous leshminiasis: a systematic review and meta analysis". [PDF]
Al-Dhubaibi MS +8 more
europepmc +1 more source
Ambiguities in cutaneous leishmaniasis classification and the need for consensus: Experience from Ethiopia. [PDF]
van Henten S +5 more
europepmc +1 more source
Mice mucosal leishmaniasis model shown high parasite load, increased cytotoxicity and impaired IL-10<sup>+</sup> T cell response. [PDF]
Da-Rocha AA +14 more
europepmc +1 more source
Miltefosine Failure and Amphotericin B Success in the Treatment of a Case of Cutaneous <i>Leishmania Braziliensis</i> in a Recent Traveler in Belize and Guatemala. [PDF]
Ko MY, Fowler E, Scott A, Uslan DZ.
europepmc +1 more source
Editorial: Drug discovery for leishmaniasis and chagas disease: compound design and therapeutic strategies. [PDF]
Kalesh K, Barbosa EG, Jordão AK.
europepmc +1 more source
The activity of miltefosine combined with oral probiotics in a mouse model of cutaneous leishmaniasis. [PDF]
Cranshoff Y +11 more
europepmc +1 more source
Hybrid reference genome assembly for the archetypal <i>Leishmania (Viannia) guyanensis</i> bearing the dsRNA totivirus LRV1. [PDF]
Myler PJ +4 more
europepmc +1 more source
Global Landscape of Molecular and Immunological Diagnostic Tests for Human Leishmaniasis: A Systematic Review and Meta-Analysis. [PDF]
Candia-Puma MA +9 more
europepmc +1 more source
An Overview of the Factors Related to <i>Leishmania</i> Vaccine Development. [PDF]
Passero LFD +4 more
europepmc +1 more source

